» Articles » PMID: 25609377

Investigating Transdermal Delivery of Vitamin D3

Overview
Publisher Springer
Specialty Pharmacology
Date 2015 Jan 23
PMID 25609377
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Transdermal delivery of therapeutic amounts of vitamin D3 is proposed to overcome its variable oral bioavailability, especially for people who suffer from fat malabsorption. The main challenge for this delivery route is to overcome the barrier properties of skin, especially for very lipophilic compounds such as vitamin D3. In this study, the effect of different penetration enhancers, such as oleic acid, dodecylamine, ethanol, oleic acid in propylene glycol, isopropyl myristate, octyldodecanol, and oleyl alcohol in propylene glycol were evaluated in vitro for their effectiveness in delivering vitamin D3 through polyamide filter, polydimethylsiloxane membrane, and porcine skin. A diffusion cell was used to study the transdermal permeability of vitamin D3. Ointment formulations of vitamin D3 were prepared containing the most widely used penetration enhancers, oleic acid, and dodecylamine. The ointment containing oleic acid as chemical penetration enhancer did not improve delivery compared to control. On the other hand, the formulation containing dodecylamine as a penetration enhancer did improve the transdermal delivery of vitamin D3. However, statistical significance and an amount high enough for nutritional supplementation purposes were reached only when the skin was pretreated with 50% ethanol. In these conditions, the ointment delivered an amount of 760-ng vitamin D3 per cm(2) of skin. The research shows promise that transdermal delivery could be an effective administration route for vitamin D3 when ethanol and dodecylamine are used as penetration enhancers.

Citing Articles

Can the use of vitamin D-fortified sunscreen cream be the solution to the vitamin D deficiency pandemic?.

Kara H, Polat U, Baykan O, Selcuk E, Turan G Arch Dermatol Res. 2025; 317(1):348.

PMID: 39912957 DOI: 10.1007/s00403-025-03837-4.


Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review.

Al-Smadi K, Ali M, Alavi S, Jin X, Imran M, Leite-Silva V Cells. 2023; 12(19).

PMID: 37830601 PMC: 10572240. DOI: 10.3390/cells12192387.


Flux-Type versus Concentration-Type Sensors in Transdermal Measurements.

Lansdorp B Biosensors (Basel). 2023; 13(9).

PMID: 37754079 PMC: 10526996. DOI: 10.3390/bios13090845.


Topical Delivery of Diacetyl Boldine in a Microemulsion Formulation for Chemoprotection against Melanoma.

Al Saqr A, Annaji M, Poudel I, Aldawsari M, Alrbyawi H, Mita N Pharmaceutics. 2023; 15(3).

PMID: 36986762 PMC: 10054442. DOI: 10.3390/pharmaceutics15030901.


Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution.

Kittaneh M, Qurt M, Malkieh N, Naseef H, Muqedi R Pharmaceutics. 2023; 15(1).

PMID: 36678668 PMC: 9863400. DOI: 10.3390/pharmaceutics15010039.


References
1.
Khazai N, Judd S, Jeng L, Wolfenden L, Stecenko A, Ziegler T . Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab. 2009; 94(6):2037-43. PMC: 2690417. DOI: 10.1210/jc.2008-2012. View

2.
Kim Y, Park J, Ludovice P, Prausnitz M . Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol. Int J Pharm. 2007; 352(1-2):129-38. DOI: 10.1016/j.ijpharm.2007.10.031. View

3.
Prasanthi D, Lakshmi P . Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride. ISRN Pharm. 2013; 2012:965280. PMC: 3539352. DOI: 10.5402/2012/965280. View

4.
Musteata F . Pharmacokinetic applications of microdevices and microsampling techniques. Bioanalysis. 2010; 1(1):171-85. DOI: 10.4155/bio.09.18. View

5.
Varshosaz J, Hajhashemi V, Soltanzadeh S . Lipid nanocapsule-based gels for enhancement of transdermal delivery of ketorolac tromethamine. J Drug Deliv. 2011; 2011:571272. PMC: 3228290. DOI: 10.1155/2011/571272. View